Jazz Pharmaceuticals (FRA:J7Z) Days Payable : 91.47 (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Jazz Pharmaceuticals Days Payable?

Jazz Pharmaceuticals's average Accounts Payable for the three months ended in Dec. 2023 was €99 Mil. Jazz Pharmaceuticals's Cost of Goods Sold for the three months ended in Dec. 2023 was €98 Mil. Hence, Jazz Pharmaceuticals's Days Payable for the three months ended in Dec. 2023 was 91.47.

The historical rank and industry rank for Jazz Pharmaceuticals's Days Payable or its related term are showing as below:

FRA:J7Z' s Days Payable Range Over the Past 10 Years
Min: 52.69 Med: 79.28 Max: 123.16
Current: 88.36

During the past 13 years, Jazz Pharmaceuticals's highest Days Payable was 123.16. The lowest was 52.69. And the median was 79.28.

FRA:J7Z's Days Payable is ranked worse than
61.34% of 714 companies
in the Biotechnology industry
Industry Median: 148.12 vs FRA:J7Z: 88.36

Jazz Pharmaceuticals's Days Payable increased from Dec. 2022 (54.56) to Dec. 2023 (91.47). It may suggest that Jazz Pharmaceuticals delayed paying its suppliers.

Jazz Pharmaceuticals Days Payable Historical Data

The historical data trend for Jazz Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jazz Pharmaceuticals Days Payable Chart

Jazz Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

121.81

94.39

51.89

62.39

82.20

Jazz Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															54.56	77.03	105.42	92.37	91.47

Competitive Comparison of Jazz Pharmaceuticals's Days Payable

For the Biotechnology subindustry, Jazz Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jazz Pharmaceuticals's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jazz Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Jazz Pharmaceuticals's Days Payable falls into.

Jazz Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Jazz Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (85.676	+	94.222)	/	2 )	/	399.424	*	365
=	89.949					/	399.424	*	365
=	82.20

Jazz Pharmaceuticals's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (102.929	+	94.222)	/	2 )	/	98.341	*	365 / 4
=	98.5755					/	98.341	*	365 / 4
=	91.47

Jazz Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Jazz Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Jazz Pharmaceuticals (FRA:J7Z) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jazz Pharmaceuticals PLC (FRA:J7Z) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

JAZZ:USA JAZZ:Mexico

Address

Waterloo Road, Fifth Floor, Waterloo Exchange, Dublin, IRL, D04 E5W7

Website

https://www.jazzpharmaceuticals.com

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Jazz Pharmaceuticals (FRA:J7Z) Headlines

No Headlines